Propolis Extract for Onychomycosis Topical Treatment: From Bench to Clinic

• Published in: Frontiers in microbiology 2018-04, Vol.9, p.779
• Main Authors: Veiga, Flavia F, Gadelha, Marina C, da Silva, Marielen R T, Costa, Maiara I, Kischkel, Brenda, de Castro-Hoshino, Lidiane V, Sato, Francielle, Baesso, Mauro L, Voidaleski, Morgana F, Vasconcellos-Pontello, Vanessa, Vicente, Vânia A, Bruschi, Marcos L, Negri, Melyssa, Svidzinski, Terezinha I E
• Format: Article
• Language: English
• Subjects: antifungal activity; dermatophytosis; ex vivo nail model; Microbiology; natural products; photoacoustic spectroscopy; propolis
• ISSN: 1664-302X; 1664-302X
• DOI: 10.3389/fmicb.2018.00779

Onychomycosis is a chronic fungal infection of nails, commonly caused by dermatophyte fungi, primarily species of . Because of the limited drug arsenal available to treat general fungal infections and the frequent failure of onychomycosis treatment, the search for new therapeutic sources is essential, and topical treatment with natural products for onychomycosis has been encouraged. Propolis, an adhesive resinous compound produced by honeybees ( ), has shown multiple biological properties including significant antifungal and anti-biofilm activities . In spite of promising results, results have not been reported so far. This study assessed an ethanol propolis extract (PE) as a topical therapeutic option for onychomycosis, including its characterization and its applicability as a treatment for onychomycosis (from bench to clinic). The evaluation included analysis of the cytotoxicity and the antifungal activity against the planktonic cells and biofilm formed by spp. We also evaluated the capacity of PE to penetrate human nails. Patients with onychomycosis received topical PE treatments, with a 6-month follow-up period. The results of the assays showed that PE was non-toxic to the cell lines tested, and efficient against both the planktonic cells and the biofilm formed by spp. The results also showed that PE is able to penetrate the human nail. The results for PE applied topically to treat onychomycosis were promising, with complete mycological and clinical cure of onychomycosis in 56.25% of the patients. PE is an inexpensive commercially available option, easy to obtain and monitor. Our results indicated that PE is a promising natural compound for onychomycosis treatment, due to its ability to penetrate the nail without cytotoxicity, and its good antifungal performance against species such as spp. that are resistant to conventional antifungals, both and in patients.